CPhI China opens as country invests in research and development

Continued growth in ingredients production with the market set for an increased R&D focus

CPhI China – hosted by UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo – returns to the Shanghai New International Exhibition Centre, SNIEC, China from 24 - 26 June 2015. The event celebrates a decade in partnership with P-MEC China and will co-locate with ICSE, BioPh, Innopack, LABWorld, Fi Asia China and Hi China.

One of the largest pharmaceutical markets in the world, China is now the leading international producer of pharmaceutical ingredients, and is forecast to reach a staggering US$154bn by 2018. The domestic industry continues to expand at a double-digit rate, driven by improvements in intellectual property protection, increased government support for R&D, alongside a gentrifying population, expanding medical coverage and growing exports.

 

This eight-shows-in-one event brings China’s entire pharmaceutical supply chain together in one location, with present than 30,000 visitors expected to attend. Running parallel to the pharma exhibitions, Fi Asia-China and Hi China will represent the burgeoning food ingredients market and the show also features Natural Extracts, Logistics, Finished Formulation, and Environmental Protection & Clean Tech zones.

 

CPhI & P-MEC China has evolved and grown alongside the market for the last 15 years: 2015 sees the floor space expanded to 140,000m2, accommodating more than 2,800 exhibitors from 100+ countries. An extensive programme of 80+ conferences, summits and seminars will feature across the three-day event, including the 6th China World CEO Summit; 2015 Pharmaceutical R&D innovation and Outsourcing Management Conversation; and 2nd BioPh China Summit 2015.

'CPhI China is an excellent exhibition for manufacturers, buyers and traders, and for sourcing new business; I very much appreciate this type of gathering. Hopefully, CPhI China will continue to return here for a long time.” Munshi Darul Islam, Proprietor & CEO, Total Pharma/Total Herbal & Nutraceuticals.

 

Erik Heemskerk, Brand Director at UBM EMEA commented: 'CPhI & P-MEC China continue to expand and meet the demand of the nation’s burgeoning pharmaceutical market. There are huge opportunities in this region for growth, exportation and development, particularly with the Government’s backing to boost the R&D sector. This event plays a critical role in bringing together both domestic and international buyers and suppliers to sustain new business partnerships and continue driving innovation.'

 

Highlights of CPhI & P-MEC China 2015:

  • Co-location with ICSE, BioPh, Innopack, LABWorld, Fi Asia China and Hi China
  • New pharma logistics zone
  • Meet with key pharma executives from across the globe and network with potential business partners
  •   
  • Extensive programme of conferences, summits and seminars gives great opportunity to learn about the latest innovations, technologies, trends and developments
  • CPhI China mobile app and 5th Buyers sourcing event to enable attendees to efficiently schedule their time